Egil Bodd

523 total citations
20 papers, 424 citations indexed

About

Egil Bodd is a scholar working on Pharmacology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Egil Bodd has authored 20 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 6 papers in Physiology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Egil Bodd's work include Pharmacogenetics and Drug Metabolism (6 papers), Pain Mechanisms and Treatments (5 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). Egil Bodd is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Pain Mechanisms and Treatments (5 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). Egil Bodd collaborates with scholars based in Norway, India and United States. Egil Bodd's co-authors include Jørg Mørland, Anders Bjørneboe, Åse Ripel, Gunn‐Elin Aa. Bjørneboe, Christian A. Drevon, N. Johnsen, Per Kragh Andersen, Dag Jacobsen, Harald Olsen and Klaus Kutz and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Antimicrobial Agents and Chemotherapy and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Egil Bodd

20 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Egil Bodd Norway 11 89 75 73 61 60 20 424
P. V. Luoma Finland 16 115 1.3× 59 0.8× 147 2.0× 74 1.2× 128 2.1× 42 687
R. M. H. Kater Australia 10 133 1.5× 105 1.4× 79 1.1× 57 0.9× 140 2.3× 16 617
Ronald Okun United States 16 42 0.5× 91 1.2× 93 1.3× 143 2.3× 71 1.2× 49 802
Peter Frost United Kingdom 12 36 0.4× 159 2.1× 39 0.5× 124 2.0× 24 0.4× 23 604
L. Orö Sweden 16 33 0.4× 102 1.4× 133 1.8× 105 1.7× 21 0.3× 25 730
Bruce P. Greenberg United States 10 22 0.2× 73 1.0× 56 0.8× 49 0.8× 23 0.4× 18 357
J. H. Galloway United Kingdom 12 36 0.4× 117 1.6× 79 1.1× 136 2.2× 11 0.2× 23 651
András Vereckei Hungary 16 28 0.3× 29 0.4× 27 0.4× 115 1.9× 56 0.9× 52 907
Victor Skrinska United States 16 56 0.6× 68 0.9× 66 0.9× 110 1.8× 13 0.2× 32 547
Ch. Fleck Germany 14 32 0.4× 89 1.2× 38 0.5× 128 2.1× 101 1.7× 78 652

Countries citing papers authored by Egil Bodd

Since Specialization
Citations

This map shows the geographic impact of Egil Bodd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Egil Bodd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Egil Bodd more than expected).

Fields of papers citing papers by Egil Bodd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Egil Bodd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Egil Bodd. The network helps show where Egil Bodd may publish in the future.

Co-authorship network of co-authors of Egil Bodd

This figure shows the co-authorship network connecting the top 25 collaborators of Egil Bodd. A scholar is included among the top collaborators of Egil Bodd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Egil Bodd. Egil Bodd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bruusgaard, Dag, et al.. (2001). Relations Between Medical History, Clinical Findings and Plasma N-Terminal Proatrial Natriuretic Peptide in Patients in Primary Health Care. European Journal of Heart Failure. 3(3). 307–313. 3 indexed citations
2.
Johansson, Inger, et al.. (1995). Biotransformation and pharmacokinetics of ethylmorphine after a single oral dose.. British Journal of Clinical Pharmacology. 39(6). 611–620. 17 indexed citations
3.
Istad, Helge, Leiv Ose, Egil Bodd, et al.. (1994). Fluvastatin efficacy and tolerability in comparison and in combination with cholestyramine. European Journal of Clinical Pharmacology. 46(5). 445–9. 22 indexed citations
4.
Halse, Johan, P. Graß, E. Abisch, et al.. (1994). A comparison of octreotide, bromocriptine, or a combination of both drugs in acromegaly.. The Journal of Clinical Endocrinology & Metabolism. 79(2). 461–465. 55 indexed citations
5.
Aasmundstad, Tor A., Åse Ripel, Egil Bodd, Anders Bjørneboe, & Jørg Mørland. (1993). Different biotransformation of morphine in isolated liver cells from guinea pig and rat. Biochemical Pharmacology. 46(6). 961–968. 29 indexed citations
6.
Andersen, Per Kragh, et al.. (1992). Oestriol in the Prophylactic Treatment of Recurrent Urinary Tract Infections in Postmenopausal Women. Scandinavian Journal of Primary Health Care. 10(2). 139–142. 60 indexed citations
7.
Hayton, William L., R. A. Walstad, J Kneer, et al.. (1991). Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in children. Antimicrobial Agents and Chemotherapy. 35(4). 720–725. 17 indexed citations
8.
Bodd, Egil, et al.. (1990). Morphine-6-Glucuronide might Mediate the Prolonged Opioid Effect of Morphine in Acute Renal Failure. Human & Experimental Toxicology. 9(5). 317–321. 55 indexed citations
9.
Bodd, Egil, et al.. (1987). Oral Administration of Codeine in the Presence of Ethanol: A Pharmacokinetic Study in Man. Pharmacology & Toxicology. 61(5). 297–300. 15 indexed citations
10.
Bodd, Egil. (1987). PHARMACOKINETIC INTERACTION BETWEEN SUBSTANCES WITH OPIOID EFFECTS AND ETHANOL. Pharmacology & Toxicology. 60(s2). 1–40. 5 indexed citations
11.
Olsen, Harald, et al.. (1986). The Effect of Ethanol Intake on Propoxyphene Absorption and Biotransformation in Dogs. Alcoholism Clinical and Experimental Research. 10(4). 393–396. 2 indexed citations
12.
Bodd, Egil, et al.. (1986). Ethanol inhibition of codeine and morphine metabolism in isolated rat hepatocytes.. Journal of Pharmacology and Experimental Therapeutics. 237(1). 260–264. 23 indexed citations
13.
Bodd, Egil, et al.. (1986). Interaction of ethanol with codeine metabolism in rat hepatocytes: a multicompartmental model. European Journal of Drug Metabolism and Pharmacokinetics. 11(3). 239–243. 5 indexed citations
14.
Bjørneboe, Anders, et al.. (1986). Transport and distribution of α-tocopherol in lymph, serum and liver cells in rats. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 889(3). 310–315. 84 indexed citations
15.
Bodd, Egil, et al.. (1986). Mechanisms behind the inhibitory effect of ethanol on the conjugation of morphine in rat hepatocytes.. Journal of Pharmacology and Experimental Therapeutics. 239(3). 887–890. 16 indexed citations
16.
Bodd, Egil, et al.. (1986). Normorphine is the Major Metabolite of Norcodeine in Isolated Rat Hepatocytes. Acta Pharmacologica et Toxicologica. 59(3). 252–253. 4 indexed citations
17.
Bodd, Egil, et al.. (1985). Lack of evidence of increased lethality due to propoxyphene overdose in the presence of ethanol in male wistar rats. Archives of Toxicology. 56(3). 170–174. 2 indexed citations
18.
Bodd, Egil, et al.. (1985). Ethanol does not increase lethality due to propoxyphene in rats. Alcohol. 2(2). 293–296. 1 indexed citations
19.
Bodd, Egil, et al.. (1985). In VitroEffect of 4‐Methylpyrazole and Pyruvate on Ethanol Interaction with Propoxyphene Metabolism in Suspensions of Isolated Rat Hepatocytes. Acta Pharmacologica et Toxicologica. 57(3). 219–222. 2 indexed citations
20.
Olsen, Harald, et al.. (1983). Ethanol interaction with propoxyphene and norpropoxyphene metabolism in isolated rat hepatocytes. Pharmacology Biochemistry and Behavior. 18. 301–304. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. V. Luoma Breakdown of academic impact, for papers by R. M. H. Kater Breakdown of academic impact, for papers by Ronald Okun Breakdown of academic impact, for papers by Peter Frost Breakdown of academic impact, for papers by L. Orö Breakdown of academic impact, for papers by Bruce P. Greenberg Breakdown of academic impact, for papers by J. H. Galloway Breakdown of academic impact, for papers by András Vereckei Breakdown of academic impact, for papers by Victor Skrinska Breakdown of academic impact, for papers by Ch. Fleck
Rankless by CCL
2026